Suppr超能文献

参与涉及跨性别青少年和青年成人的HIV暴露前预防试验的促进因素和障碍

Facilitators and Barriers to Participation in PrEP HIV Prevention Trials Involving Transgender Male and Female Adolescents and Emerging Adults.

作者信息

Fisher Celia B, Fried Adam L, Desmond Margaret, Macapagal Kathryn, Mustanski Brian

机构信息

Fordham University Center for Ethics Education, Bronx, New York.

Northwestern University, Feinberg School of Medicine, Chicago, Illinois.

出版信息

AIDS Educ Prev. 2017 Jun;29(3):205-217. doi: 10.1521/aeap.2017.29.3.205.

Abstract

Despite the disproportionate burden of HIV facing transgender youth, they continue to be under-represented in studies to provide an empirical basis for pre-exposure prophylaxis (PrEP) programs that can meet the unique needs of this population. This study examined facilitators and barriers to participation in a PrEP adherence study, determined through an online survey administered to 90 transgender male and 60 transgender female 14-21-year-olds attracted to cisgender male sexual partners. Approximately 50% reported likely to participate in the PrEP study. Participation facilitators included prior sexual and health service experiences and study access to PrEP and health services. Participation barriers included lack of concern about HIV, potential medication side effects, the logistics of quarterly meetings, remembering to take PrEP daily, and reluctance to discuss gender identity with study staff. Results suggest that successful recruitment and retention of transgender youth in PrEP prevention studies warrant protocols designed to address these barriers.

摘要

尽管跨性别青少年面临着不成比例的艾滋病毒负担,但在为能满足该人群独特需求的暴露前预防(PrEP)项目提供实证依据的研究中,他们的代表性仍然不足。本研究通过对90名被顺性别男性性伴侣吸引的14至21岁跨性别男性和60名跨性别女性进行在线调查,考察了参与PrEP依从性研究的促进因素和障碍。约50%的人表示可能参与PrEP研究。参与的促进因素包括先前的性和健康服务经历以及研究中可获得PrEP和健康服务。参与障碍包括对艾滋病毒缺乏关注、潜在的药物副作用、季度会议的安排、每天记得服用PrEP以及不愿与研究人员讨论性别认同。结果表明,要在PrEP预防研究中成功招募和留住跨性别青少年,需要制定旨在解决这些障碍的方案。

相似文献

引用本文的文献

本文引用的文献

8
Integrated and Gender-Affirming Transgender Clinical Care and Research.综合且肯定性别的跨性别临床护理与研究
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3(Suppl 3):S235-42. doi: 10.1097/QAI.0000000000001088.
9
Pharmacologic Considerations for Preexposure Prophylaxis in Transgender Women.变性女性暴露前预防的药理学考量
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3(Suppl 3):S230-4. doi: 10.1097/QAI.0000000000001105.
10
Transgender Women in Clinical Trials of Pre-Exposure Prophylaxis.暴露前预防临床试验中的跨性别女性
J Acquir Immune Defic Syndr. 2016 Aug 15;72 Suppl 3(Suppl 3):S226-9. doi: 10.1097/QAI.0000000000001090.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验